Krop Julie 4
4 · Aquestive Therapeutics, Inc. · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Krop Julie
Director
Transactions
- Award
Stock Option (Right to Purchase)
2025-06-11$3.41/sh+42,000$143,220→ 42,000 totalExercise: $3.41From: 2026-06-11Exp: 2035-06-11→ Common Stock (42,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date.